Fulcrum Therapeutics, Inc

(NASDAQ:FULC)

Latest On Fulcrum Therapeutics, Inc (FULC):

Date/Time Type Description Signal Details
2023-05-24 17:06 ESTNewsFulcrum Therapeutics: FSHD Steadily Advancing In Phase 3, Optionality With SCDN/A
2023-05-16 00:01 ESTNewsFulcrum Therapeutics, Inc. (FULC) Q1 2023 Earnings Call TranscriptN/A
2023-05-15 10:14 ESTNewsFulcrum Therapeutics GAAP EPS of -$0.41 beats by $0.05, revenue of $0.3M misses by $0.68MN/A
2023-05-15 10:14 ESTNewsFulcrum Therapeutics appoints new executive chiefN/A
2023-05-05 01:13 ESTNewsFulcrum slips as Goldman Sachs downgrades on limited catalyst pathN/A
2023-04-25 17:38 ESTNewsFulcrum Therapeutics: Barrage Of Bad News In 2023 But Key Catalysts RemainN/A
2023-04-05 22:41 ESTNewsFulcrum Therapeutics CFO resignsN/A
2023-03-10 23:32 ESTNewsFulcrum Therapeutics downgraded to neutral at Credit Suisse on sickle cell candidateN/A
2023-03-10 23:31 ESTNewsFulcrum Therapeutics, Inc. (FULC) Q4 2022 Earnings Call TranscriptN/A
2023-03-09 16:52 ESTNewsFulcrum Therapeutics GAAP EPS of -$0.50 misses by $0.01, revenue of $0.7M misses by $1.19MN/A
2023-03-09 16:52 ESTNewsFulcrum plunges 23% after Q4 update as medical chief departsN/A
2023-02-24 17:52 ESTNewsFulcrum Therapeutics plunges 55% on clinical hold for sickle cell treatmentsN/A
2023-02-13 20:23 ESTNewsFulcrum's Losmapimod: A Potential Aid, But Its Ability To Modify The Disease Remains UncertainN/A
2023-01-18 07:27 ESTNewsFulcrum Therapeutics shares slide after pricing $125M upsized stock offeringN/A
2023-01-17 20:15 ESTNewsFulcrum Therapeutics commences $100M underwritten public offering of sharesN/A
2023-01-04 19:34 ESTNewsFulcrum Therapeutics names new CEO and provides business outlookN/A
2022-11-12 22:51 ESTNewsFulcrum Therapeutics, Inc. (FULC) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 12:30 ESTNewsFulcrum Therapeutics GAAP EPS of -$0.51 beats by $0.11, revenue of $1.18M misses by $1.36MN/A
2022-11-07 19:00 ESTNewsFulcrum Therapeutics names new chief medical officer, chief scientific officerN/A
2022-08-16 08:01 ESTNewsFulcrum Therapeutics stock dips on offering of $75M sharesN/A
2022-08-16 08:01 ESTNewsFulcrum prices ~$75M stock offeringN/A
2022-08-12 02:43 ESTNewsFulcrum Therapeutics, Inc. (FULC) CEO Bryan Stuart on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 09:44 ESTNewsFulcrum Therapeutics GAAP EPS of -$0.83 misses by $0.17, revenue of $1.9M misses by $1.06MN/A
2022-07-11 19:26 ESTNewsFulcrum Therapeutics says chief medical officer Christopher Morabito to leaveN/A
2022-07-06 05:55 ESTNewsFulcrum begins dosing in late-stage study of losmapimod for rare muscle disorderN/A
2022-06-28 04:00 ESTNewsFulcrum Therapeutics: Value Loss On SCD Data Update Is TellingN/A
2022-06-10 23:46 ESTNewsFulcrum crashes 48% after announcing early-stage data sickle cell disease candidateN/A
2022-06-08 03:53 ESTNewsFulcrum gains as Merck ends deal for lung disease candidatesN/A
2022-05-10 06:03 ESTNewsFulcrum Therapeutics' (FULC) CEO Bryan Stuart on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-09 10:26 ESTNewsFulcrum Therapeutics GAAP EPS of -$0.64 misses by $0.02, revenue of $2.6M misses by $1.34MN/A
2022-03-08 13:53 ESTNewsFulcrum rises as Oppenheimer highlights sickle cell disease candidateN/A
2022-03-03 11:48 ESTNewsFulcrum Therapeutics GAAP EPS of -$0.58 beats by $0.09, revenue of $5.06M beats by $1.54MN/A
2022-03-03 11:48 ESTNewsFulcrum plans phase 3 trial of losmapimod to treat rare muscle disorderN/A
2022-03-03 11:48 ESTNewsFulcrum Therapeutics, Inc.'s (FULC) CEO Bryan Stuart On Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-11 21:58 ESTNewsFulcrum Therapeutics grants inducement options to one new employeeN/A
2022-01-08 15:26 ESTNewsBiogen, Galapagos and Ultragenyx among key biotech calls at Morgan Stanley for 2022N/A
2022-01-04 13:05 ESTNewsFulcrum Therapeutics hires CFON/A
2021-11-06 20:44 ESTNewsFulcrum Therapeutics, Inc. (FULC) CEO Bryan Stuart on Q3 2021 results - Earnings Call TranscriptN/A
2021-09-03 15:55 ESTNewsFulcrum Therapeutics: Multiple Interesting Programs, Needs A Better Entry PointN/A
2021-08-12 17:25 ESTNewsFulcrum Therapeutics raises $125M via equity offeringN/A
2021-08-11 21:00 ESTNewsBluebird bio price target cut; Fulcrum upgraded as Morgan Stanley shakes up SCD coverageN/A
2021-08-11 01:17 ESTNewsFulcrum Therapeutics surges on early-stage results for sickle cell disease therapyN/A
2021-08-11 01:16 ESTNewsFulcrum Therapeutics, Inc. (FULC) CEO Bryan Stuart on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-11 01:15 ESTNewsFulcrum Therapeutics more than doubles as Stifel raises price targetN/A
2021-08-11 01:15 ESTNewsFulcrum Therapeutics shares under pressure after $100M capital raiseN/A
2021-07-21 09:26 ESTNewsFulcrum Therapeutics reports results mid-stage losmapimod study in rare disabling diseaseN/A
2021-07-21 09:26 ESTNewsStifel nearly doubles Fulcrum price target, assumes 354% upsideN/A
2021-07-21 09:24 ESTNewsMRIN, ALT, FLXN and FULC among after-hours moversN/A
2021-05-06 12:07 ESTNewsFulcrum Therapeutics beats on revenueN/A
2021-05-06 12:06 ESTNewsFulcrum Therapeutics has a new medical chiefN/A

About Fulcrum Therapeutics, Inc (FULC):

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that is in Phase 2b clinical trial for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive, and disabling muscle wasting disorder that leads to significant physical impairments and disability; and FTX-6058, a small molecule designed to upregulate fetal hemoglobin in patients with sickle cell disease and ß-thalassemia. The company is also discovering drug targets for the treatments of muscle, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. Fulcrum Therapeutics, Inc. has research and discovery collaboration agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; and has a strategic collaboration and license agreement with MyoKardia, Inc. to discover, develop, and commercialize novel targeted therapies for the treatment of genetic cardiomyopathies. Fulcrum Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.

FULC Quotes by TradingView

See Advanced Chart

General

  • Name Fulcrum Therapeutics, Inc
  • Symbol FULC
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 73
  • Fiscal Year EndDecember
  • IPO Date2019-07-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Web URLhttp://www.fulcrumtx.com
View More

Valuation

  • Trailing PE 267
  • Price/Sales (Trailing 12 Mt.) 34.37
  • Price/Book (Most Recent Quarter) 4.11
  • Enterprise Value Revenue 31.49
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.87
  • Next Year EPS Estimate -$3.06
  • Next Quarter EPS Estimate -$0.66
  • Operating Margin -812%
  • Return on Assets -37%
  • Return on Equity -78%
  • Revenue 8.82 million
  • Earnings Per Share -$50.40
  • Revenue Per Share $0.35
  • Gross Profit -46839000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 405.79 million
  • EBITDA -67074000
  • PE Ratio -26.37
  • Analyst Target Price $18
  • Book Value Per Share $4.53
View More

Share Statistics

  • Shares Outstanding 32.67 million
  • Shares Float 18.96 million
  • % Held by Insiders 3552%
  • % Held by Institutions 76.11%
  • Shares Short 690946
  • Shares Short Prior Month 724097
  • Short Ratio 4.81
  • Short % of Float 3%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • 52 Week High $22.39
  • 52 Week Low $7.01
  • 50 Day Moving Average 12.75
  • 200 Day Moving Average 11.21
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Fulcrum Therapeutics, Inc (FULC) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Fulcrum Therapeutics, Inc (FULC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-04$4.23 million-$0.63-$0.7313.1%
2020-09-302020-11-10$N/A-$0.70-$0.64-9.8%
2020-06-302020-08-11$N/A-$0.66-$0.7511.61%
2020-03-312020-05-13$750000-$0.81-$0.76-6.58%
2019-12-312020-03-05$N/A-$0.71-$0.8819.62%
2019-09-302019-11-14$N/A-$0.97-$0.72-34.72%
2019-06-302019-08-26$N/A-$0.71-$0.755.33%

Fulcrum Therapeutics, Inc (FULC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Fulcrum Therapeutics, Inc (FULC) Chart:

Fulcrum Therapeutics, Inc (FULC) News:

Below you will find a list of latest news for Fulcrum Therapeutics, Inc (FULC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Fulcrum Therapeutics, Inc (FULC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-1610CALL0 0442.22TRUE00
2025-05-1620CALL0 0338.54TRUE00
2025-05-1630CALL0 0252.36TRUE00
2025-05-1640.05CALL0 48233.04FALSE00
2025-05-1650.05CALL0 1229.64FALSE00
2025-05-1660CALL0 0339.4FALSE00
2025-05-1670CALL0 0385.41FALSE00
2025-05-1610PUT0 00FALSE00
2025-05-1620.05PUT0 40175.59FALSE00
2025-05-1630.35PUT0 1241.21FALSE00
2025-05-1640PUT0 0173.15TRUE00
2025-05-1650PUT0 0258.77TRUE00
2025-05-1660PUT0 0243.84TRUE00
2025-05-1670PUT0 0347.02TRUE00
2025-06-2010CALL0 0455.66TRUE00
2025-06-2021.27CALL0 53165.23TRUE00
2025-06-2031CALL0 5168.27TRUE00
2025-06-2040.25CALL0 99107.69FALSE00
2025-06-2050.25CALL0 308141.94FALSE00
2025-06-2060.45CALL0 86186.65FALSE00
2025-06-2070CALL0 0329.84FALSE00
2025-06-2080.15CALL0 1224.27FALSE00
2025-06-20100.15CALL0 15264.27FALSE00
2025-06-2010PUT0 0449.98FALSE00
2025-06-2020PUT0 0199.63FALSE00
2025-06-2030.32PUT0 4107.28FALSE00
2025-06-2041.15PUT0 662.82TRUE00
2025-06-2051.6PUT0 10109.1TRUE00
2025-06-2060PUT0 080.86TRUE00
2025-06-2070PUT0 099.17TRUE00
2025-06-2080PUT0 0141.44TRUE00
2025-06-20100PUT0 0187.26TRUE00
2025-09-1910CALL0 0151.74TRUE00
2025-09-1920CALL0 0126.76TRUE00
2025-09-1930CALL0 097.77TRUE00
2025-09-1940.5CALL0 1799.07FALSE00
2025-09-1950.42CALL0 10101.43FALSE00
2025-09-1960.56CALL0 15105.7FALSE00
2025-09-1970CALL0 0120.14FALSE00
2025-09-1980CALL0 0131.87FALSE00
2025-09-1910PUT0 0281.39FALSE00
2025-09-1920PUT0 0145.94FALSE00
2025-09-1930.7PUT0 34108.92FALSE00
2025-09-1940PUT0 087.3TRUE00
2025-09-1950PUT0 081.25TRUE00
2025-09-1960PUT0 057.32TRUE00
2025-09-1970PUT0 093.86TRUE00
2025-09-1980PUT0 080.89TRUE00
2025-12-1910CALL0 0154.9TRUE00
2025-12-1920CALL0 084.55TRUE00
2025-12-1930.83CALL0 84104.82TRUE00
2025-12-1940.65CALL0 797.16FALSE00
2025-12-1950.5CALL0 18398.91FALSE00
2025-12-1960CALL0 096.46FALSE00
2025-12-1970.05CALL0 14101.14FALSE00
2025-12-19100.65CALL0 38191.12FALSE00
2025-12-19120.21CALL0 64200.57FALSE00
2025-12-19150.1CALL0 10162.01FALSE00
2025-12-19170CALL0 0192.45FALSE00
2025-12-1910PUT0 0256.22FALSE00
2025-12-1920.25PUT0 7116.04FALSE00
2025-12-1930.75PUT0 895.09FALSE00
2025-12-1940PUT0 086.18TRUE00
2025-12-1952PUT0 791.75TRUE00
2025-12-1960PUT0 092.33TRUE00
2025-12-1974.1PUT0 489.81TRUE00
2025-12-19106.99PUT0 0133.18TRUE00
2025-12-19120PUT0 0136.12TRUE00
2025-12-19150PUT0 0140.03TRUE00
2025-12-19170PUT0 0161.38TRUE00
2026-01-1610CALL0 0145.88TRUE00
2026-01-1620CALL0 0115.11TRUE00
2026-01-1630.81CALL0 142106.52TRUE00
2026-01-1640CALL0 0100.3FALSE00
2026-01-1650CALL0 0101.66FALSE00
2026-01-1660.7CALL0 1105.88FALSE00
2026-01-1670.75CALL0 597.72FALSE00
2026-01-16100CALL0 0144.97FALSE00
2026-01-1610PUT0 0242.99FALSE00
2026-01-1620PUT0 0144.06FALSE00
2026-01-1630PUT0 0103.16FALSE00
2026-01-1640PUT0 090.68TRUE00
2026-01-1650PUT0 079.02TRUE00
2026-01-1660PUT0 092.7TRUE00
2026-01-1674PUT0 186.05TRUE00
2026-01-16100PUT0 0132.13TRUE00
2027-01-1510CALL0 0100.62TRUE00
2027-01-1521.66CALL0 1125.85TRUE00
2027-01-1530CALL0 0150.26TRUE00
2027-01-1541.9CALL0 6164.66FALSE00
2027-01-1551.5CALL0 4174.75FALSE00
2027-01-1570.71CALL0 782.65FALSE00
2027-01-15100CALL0 0202.1FALSE00
2027-01-1510PUT0 00FALSE00
2027-01-1520PUT0 0131.66FALSE00
2027-01-1531PUT0 5097.36FALSE00
2027-01-1541.55PUT0 276.31TRUE00
2027-01-1551.98PUT0 388.74TRUE00
2027-01-1574.45PUT0 084.14TRUE00
2027-01-15100PUT0 085.95TRUE00

Latest FULC Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST48$4.18
Jun 13, 2022 7:59 PM EST10$4.18
Jun 13, 2022 7:59 PM EST100$4.185
Jun 13, 2022 7:59 PM EST100$4.18
Jun 13, 2022 7:59 PM EST112$4.18

Fulcrum Therapeutics, Inc (FULC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320018278/0000899243-20-018278-index.htm
2019-05-29UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1680581/000000000019009042/0000000000-19-009042-index.htm
2019-06-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1680581/000000000019009993/0000000000-19-009993-index.htm
2020-06-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1680581/000000000020005645/0000000000-20-005645-index.htm
2020-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1680581/000000000020007385/0000000000-20-007385-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000031506620000982/0000315066-20-000982-index.htm
2020-09-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000089914020000435/0000899140-20-000435-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924319019806/0000899243-19-019806-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924319019807/0000899243-19-019807-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924319019809/0000899243-19-019809-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924319020026/0000899243-19-020026-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924319020029/0000899243-19-020029-index.htm
2019-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924319020073/0000899243-19-020073-index.htm
2020-01-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320000461/0000899243-20-000461-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320000462/0000899243-20-000462-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320002034/0000899243-20-002034-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320002035/0000899243-20-002035-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320002037/0000899243-20-002037-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320002040/0000899243-20-002040-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320002041/0000899243-20-002041-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320003272/0000899243-20-003272-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320005299/0000899243-20-005299-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320005300/0000899243-20-005300-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320005958/0000899243-20-005958-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320006590/0000899243-20-006590-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320012820/0000899243-20-012820-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320012822/0000899243-20-012822-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320014415/0000899243-20-014415-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320014416/0000899243-20-014416-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320014552/0000899243-20-014552-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320014719/0000899243-20-014719-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320014721/0000899243-20-014721-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320015063/0000899243-20-015063-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320015437/0000899243-20-015437-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320015784/0000899243-20-015784-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320015959/0000899243-20-015959-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320016382/0000899243-20-016382-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320016496/0000899243-20-016496-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320016497/0000899243-20-016497-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320016498/0000899243-20-016498-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320016499/0000899243-20-016499-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320016500/0000899243-20-016500-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320017758/0000899243-20-017758-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320017761/0000899243-20-017761-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320018121/0000899243-20-018121-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320018278/0000899243-20-018278-index.htm
2020-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320018815/0000899243-20-018815-index.htm
2020-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320018817/0000899243-20-018817-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320024982/0000899243-20-024982-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000090342319000302/0000903423-19-000302-index.htm
2019-05-01DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1680581/000091205719000198/0000912057-19-000198-index.htm
2019-06-06DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1680581/000091205719000241/0000912057-19-000241-index.htm
2020-02-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000091957420001785/0000919574-20-001785-index.htm
2019-06-21S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1680581/000104746919003793/0001047469-19-003793-index.htm
2019-07-08S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1680581/000104746919004014/0001047469-19-004014-index.htm
2019-07-12S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1680581/000104746919004158/0001047469-19-004158-index.htm
2019-07-18424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1680581/000104746919004265/0001047469-19-004265-index.htm
2019-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000104746919004324/0001047469-19-004324-index.htm
2019-06-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1680581/000110465919037024/0001104659-19-037024-index.htm
2019-06-26CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1680581/000110465919037583/0001104659-19-037583-index.htm
2019-07-128-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1680581/000110465919040208/0001104659-19-040208-index.htm
2019-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040331/0001104659-19-040331-index.htm
2019-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040333/0001104659-19-040333-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040809/0001104659-19-040809-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040810/0001104659-19-040810-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040811/0001104659-19-040811-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040812/0001104659-19-040812-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040813/0001104659-19-040813-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040814/0001104659-19-040814-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040815/0001104659-19-040815-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040816/0001104659-19-040816-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040817/0001104659-19-040817-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040818/0001104659-19-040818-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040819/0001104659-19-040819-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040820/0001104659-19-040820-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040821/0001104659-19-040821-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040965/0001104659-19-040965-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040966/0001104659-19-040966-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040967/0001104659-19-040967-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040968/0001104659-19-040968-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040969/0001104659-19-040969-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040970/0001104659-19-040970-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040971/0001104659-19-040971-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040972/0001104659-19-040972-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040973/0001104659-19-040973-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919041303/0001104659-19-041303-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919041304/0001104659-19-041304-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919041306/0001104659-19-041306-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919041307/0001104659-19-041307-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000110465920020454/0001104659-20-020454-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000114036119013355/0001140361-19-013355-index.htm
2019-07-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000114420419036332/0001144204-19-036332-index.htm
2019-07-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000119312519204925/0001193125-19-204925-index.htm
2019-08-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312519228512/0001193125-19-228512-index.htm
2019-08-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1680581/000119312519228520/0001193125-19-228520-index.htm
2019-10-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312519262065/0001193125-19-262065-index.htm
2019-12-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312519325397/0001193125-19-325397-index.htm
2020-01-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312520001768/0001193125-20-001768-index.htm
2020-02-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000119312520025424/0001193125-20-025424-index.htm
2020-02-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000119312520025429/0001193125-20-025429-index.htm
2020-03-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1680581/000119312520063092/0001193125-20-063092-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1680581/000119312520124813/0001193125-20-124813-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1680581/000119312520124825/0001193125-20-124825-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312520165696/0001193125-20-165696-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312520166654/0001193125-20-166654-index.htm
2020-06-22S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1680581/000119312520175588/0001193125-20-175588-index.htm
2020-06-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1680581/000119312520177487/0001193125-20-177487-index.htm
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312520181057/0001193125-20-181057-index.htm
2020-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312520197820/0001193125-20-197820-index.htm
2020-08-11S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1680581/000119312520215668/0001193125-20-215668-index.htm
2020-08-11POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1680581/000119312520215674/0001193125-20-215674-index.htm
2020-08-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1680581/000119312520219029/0001193125-20-219029-index.htm
2019-07-15CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1680581/000135445719000348/0001354457-19-000348-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000138713120001784/0001387131-20-001784-index.htm
2019-06-05DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1680581/000141057819000287/0001410578-19-000287-index.htm
2019-08-2610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1680581/000156459019032952/0001564590-19-032952-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000156459019043359/0001564590-19-043359-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1680581/000156459019043378/0001564590-19-043378-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000156459020008800/0001564590-20-008800-index.htm
2020-03-0510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1680581/000156459020008951/0001564590-20-008951-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000156459020014860/0001564590-20-014860-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000156459020024846/0001564590-20-024846-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1680581/000156459020024866/0001564590-20-024866-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000156459020039117/0001564590-20-039117-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1680581/000156459020039121/0001564590-20-039121-index.htm
2016-07-25DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000168058116000001/0001680581-16-000001-index.htm
2017-05-10DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000168058117000001/0001680581-17-000001-index.htm
2017-07-25D/ANotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000168058117000002/0001680581-17-000002-index.htm
2018-09-05DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000168058118000002/0001680581-18-000002-index.htm
2020-06-11DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000168058120000001/0001680581-20-000001-index.htm
2019-07-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1680581/999999999519001628/9999999995-19-001628-index.htm
2020-06-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1680581/999999999520001702/9999999995-20-001702-index.htm
2020-08-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1680581/999999999520002111/9999999995-20-002111-index.htm
2020-08-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1680581/999999999520002175/9999999995-20-002175-index.htm
2019-05-13SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1680581/999999999719004388/9999999997-19-004388-index.htm
2019-06-20SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1680581/999999999719005683/9999999997-19-005683-index.htm

Fulcrum Therapeutics, Inc (FULC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Fulcrum Therapeutics, Inc (FULC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3552%
Institutional Ownership: 7611%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-02-19Owen B. WallaceChief Scientific OfficerSell6,088.0020.00121,760.00127,088.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320005299/0000899243-20-005299-index.htm
2020-05-26Owen B. WallaceChief Scientific OfficerSell412.0020.008,240.00127,088.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014416/0000899243-20-014416-index.htm
2020-05-27Owen B. WallaceChief Scientific OfficerSell448.0020.008,960.00127,088.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014552/0000899243-20-014552-index.htm
2020-05-28Owen B. WallaceChief Scientific OfficerSell2,232.0020.0044,640.00127,088.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014719/0000899243-20-014719-index.htm
2020-06-30Owen B. WallaceChief Scientific OfficerSell141.0020.002,820.00127,088.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320018121/0000899243-20-018121-index.htm
2020-07-08Owen B. WallaceChief Scientific OfficerSell2,951.0020.0059,020.00127,088.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320018817/0000899243-20-018817-index.htm
2020-06-30Owen B. WallaceChief Scientific OfficerBuy141.007.841,105.44127,229.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320018121/0000899243-20-018121-index.htm
2020-05-26Owen B. WallaceChief Scientific OfficerBuy412.007.843,230.08127,500.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014416/0000899243-20-014416-index.htm
2020-05-27Owen B. WallaceChief Scientific OfficerBuy448.007.843,512.32127,536.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014552/0000899243-20-014552-index.htm
2020-05-28Owen B. WallaceChief Scientific OfficerBuy2,232.007.8417,498.88129,320.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014719/0000899243-20-014719-index.htm
2020-07-08Owen B. WallaceChief Scientific OfficerBuy2,951.007.8423,135.84130,039.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320018817/0000899243-20-018817-index.htm
2020-02-19Owen B. WallaceChief Scientific OfficerBuy6,088.007.8447,729.92133,176.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320005299/0000899243-20-005299-index.htm
2020-09-14Owen B. WallaceChief Scientific OfficerBuy6,350.007.8449,784.00133,438.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320024982/0000899243-20-024982-index.htm
2020-05-11Peter G. ThomsonVP Finance & AccountingSell7,500.0016.00120,000.0021,071.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320012820/0000899243-20-012820-index.htm
2019-07-22Third Rock Ventures IV, L.P.10% Share HolderBuy81,250.0016.001,300,000.002,343,154.00https://www.sec.gov/Archives/edgar/data/1680581/000089924319020029/0000899243-19-020029-index.htm
2020-02-24Peter G. ThomsonVP Finance & AccountingSell250.0018.614,653.0028,571.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320005958/0000899243-20-005958-index.htm
2020-02-24Peter G. ThomsonVP Finance & AccountingSell2,102.0017.4336,643.3328,821.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320005958/0000899243-20-005958-index.htm
2020-02-24Peter G. ThomsonVP Finance & AccountingSell2,648.0016.1842,856.5630,923.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320005958/0000899243-20-005958-index.htm
2020-01-23Peter G. ThomsonVP Finance & AccountingSell262.0018.054,730.1233,571.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320002037/0000899243-20-002037-index.htm
2020-01-23Peter G. ThomsonVP Finance & AccountingSell4,738.0017.1781,371.8333,833.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320002037/0000899243-20-002037-index.htm
2020-07-08Robert J GouldOfficerSell2,500.0020.0050,000.00534,845.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320018815/0000899243-20-018815-index.htm
2020-06-25Robert J GouldOfficerSell2,500.0020.8051,992.00537,345.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320017758/0000899243-20-017758-index.htm
2020-06-09Robert J GouldOfficerSell156.0020.003,120.00539,845.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015959/0000899243-20-015959-index.htm
2020-06-05Robert J GouldOfficerSell3,433.0020.1769,251.16540,001.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015784/0000899243-20-015784-index.htm
2020-06-04Robert J GouldOfficerSell1,300.0020.0426,057.98543,434.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015437/0000899243-20-015437-index.htm
2020-06-03Robert J GouldOfficerSell1,500.0020.1330,192.45544,734.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015437/0000899243-20-015437-index.htm
2020-06-02Robert J GouldOfficerSell2,797.0020.0055,940.00546,234.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015063/0000899243-20-015063-index.htm
2020-06-01Robert J GouldOfficerSell5.0020.00100.00549,031.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015063/0000899243-20-015063-index.htm
2020-05-29Robert J GouldOfficerSell1,390.0020.0827,910.78549,036.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014721/0000899243-20-014721-index.htm
2020-05-28Robert J GouldOfficerSell1,919.0020.0138,391.13550,426.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014721/0000899243-20-014721-index.htm
2020-05-26Robert J GouldOfficerSell2,500.0020.0050,000.00552,345.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014415/0000899243-20-014415-index.htm
2020-02-19Robert J GouldOfficerSell2,500.0020.0050,000.00554,845.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320005300/0000899243-20-005300-index.htm
2019-07-22 Sanofi10% Share HolderBuy93,750.0016.001,500,000.00558,035.00https://www.sec.gov/Archives/edgar/data/1680581/000089924319020073/0000899243-19-020073-index.htm
2019-07-226 Dimensions Capital, L.P.10% Share HolderBuy118,750.0016.001,900,000.00559,821.00https://www.sec.gov/Archives/edgar/data/1680581/000110465919041307/0001104659-19-041307-index.htm
2019-07-22Casdin Capital, LLC10% Share HolderBuy125,000.0016.002,000,000.00589,285.00https://www.sec.gov/Archives/edgar/data/1680581/000110465919041306/0001104659-19-041306-index.htm
2019-07-22MARK J LEVINDirectorBuy81,250.0016.001,300,000.005,962,202.00https://www.sec.gov/Archives/edgar/data/1680581/000110465919041304/0001104659-19-041304-index.htm
2019-07-22Third Rock Ventures III, L.P.10% Share HolderBuy81,250.0016.001,300,000.005,962,202.00https://www.sec.gov/Archives/edgar/data/1680581/000089924319020026/0000899243-19-020026-index.htm
2019-07-22Casdin Capital, LLC10% Share HolderBuy10,000.0014.50144,996.00599,285.00https://www.sec.gov/Archives/edgar/data/1680581/000110465919041306/0001104659-19-041306-index.htm
2019-07-22Casdin Capital, LLC10% Share HolderBuy5,000.0014.5072,499.00604,285.00https://www.sec.gov/Archives/edgar/data/1680581/000110465919041306/0001104659-19-041306-index.htm
2020-07-01Diego CadavidSVP Clinical DevelopmentSell1,071.0018.3019,599.3065,714.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320018278/0000899243-20-018278-index.htm
2020-03-02Diego CadavidSVP Clinical DevelopmentSell315.0018.135,709.5366,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320006590/0000899243-20-006590-index.htm
2020-05-12Diego CadavidSVP Clinical DevelopmentSell1,860.0018.0033,480.0066,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320012822/0000899243-20-012822-index.htm
2020-05-28Diego CadavidSVP Clinical DevelopmentSell600.0020.0012,000.0066,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-05-29Diego CadavidSVP Clinical DevelopmentSell200.0020.044,007.0066,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-06-02Diego CadavidSVP Clinical DevelopmentSell45.0020.00900.0066,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-06-03Diego CadavidSVP Clinical DevelopmentSell338.0020.186,819.5966,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-06-04Diego CadavidSVP Clinical DevelopmentSell226.0020.054,531.2566,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-06-05Diego CadavidSVP Clinical DevelopmentSell451.0020.189,100.7766,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-06-10Diego CadavidSVP Clinical DevelopmentSell401.0022.008,822.0066,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320016382/0000899243-20-016382-index.htm
2020-06-25Diego CadavidSVP Clinical DevelopmentSell1,459.0022.0032,098.0066,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320017761/0000899243-20-017761-index.htm
2020-06-02Diego CadavidSVP Clinical DevelopmentBuy45.004.83217.3566,830.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-05-29Diego CadavidSVP Clinical DevelopmentBuy200.004.83966.0066,985.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-06-04Diego CadavidSVP Clinical DevelopmentBuy226.004.831,091.5867,011.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-03-02Diego CadavidSVP Clinical DevelopmentSell1,828.0017.2631,545.2567,100.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320006590/0000899243-20-006590-index.htm
2020-06-03Diego CadavidSVP Clinical DevelopmentBuy338.004.831,632.5467,123.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-06-10Diego CadavidSVP Clinical DevelopmentBuy401.004.831,936.8367,186.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320016382/0000899243-20-016382-index.htm
2020-06-05Diego CadavidSVP Clinical DevelopmentBuy451.004.832,178.3367,236.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-05-28Diego CadavidSVP Clinical DevelopmentBuy600.004.832,898.0067,385.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-06-25Diego CadavidSVP Clinical DevelopmentBuy1,459.004.837,046.9768,244.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320017761/0000899243-20-017761-index.htm
2020-05-12Diego CadavidSVP Clinical DevelopmentBuy1,860.004.838,983.8068,645.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320012822/0000899243-20-012822-index.htm
2020-02-03Diego CadavidSVP Clinical DevelopmentSell2,143.0017.3337,141.8368,928.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320003272/0000899243-20-003272-index.htm